Uscom Limited (UCM.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.4 Million AUD | 17.56% |
| 2023 | -2.91 Million AUD | -11.96% |
| 2022 | -2.6 Million AUD | -81.82% |
| 2021 | -1.43 Million AUD | 20.32% |
| 2020 | -1.79 Million AUD | -30.34% |
| 2019 | -1.37 Million AUD | 29.31% |
| 2018 | -1.95 Million AUD | -9.0% |
| 2017 | -1.79 Million AUD | 5.94% |
| 2016 | -1.9 Million AUD | -64.67% |
| 2015 | -1.15 Million AUD | 29.46% |
| 2014 | -1.63 Million AUD | 8.39% |
| 2013 | -1.78 Million AUD | 19.21% |
| 2012 | -2.21 Million AUD | 23.96% |
| 2011 | -2.91 Million AUD | -34.38% |
| 2010 | -2.16 Million AUD | -12.35% |
| 2009 | -1.92 Million AUD | 24.61% |
| 2008 | -2.55 Million AUD | 41.41% |
| 2007 | -4.36 Million AUD | -2.96% |
| 2006 | -4.24 Million AUD | -17.78% |
| 2005 | -3.6 Million AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.08 Million AUD | 0.0% |
| 2024 Q4 | -1.56 Million AUD | 0.0% |
| 2024 FY | -2.37 Million AUD | 18.53% |
| 2023 FY | -2.91 Million AUD | -11.96% |
| 2023 Q4 | -1.34 Million AUD | 0.0% |
| 2023 Q2 | -1.57 Million AUD | 0.0% |
| 2022 Q4 | -1.21 Million AUD | 0.0% |
| 2022 FY | -2.6 Million AUD | -81.82% |
| 2022 Q2 | -1.39 Million AUD | 0.0% |
| 2021 Q2 | -672.8 Thousand AUD | 0.0% |
| 2021 Q4 | -759.93 Thousand AUD | 0.0% |
| 2021 FY | -1.43 Million AUD | 20.32% |
| 2020 FY | -1.79 Million AUD | -30.34% |
| 2020 Q4 | -75.15 Thousand AUD | 0.0% |
| 2020 Q2 | -1.72 Million AUD | 0.0% |
| 2019 FY | -1.37 Million AUD | 29.31% |
| 2019 Q4 | -998.16 Thousand AUD | 0.0% |
| 2019 Q2 | -752.9 Thousand AUD | 0.0% |
| 2018 Q4 | -870.64 Thousand AUD | 0.0% |
| 2018 FY | -1.95 Million AUD | -9.0% |
| 2018 Q2 | -1.08 Million AUD | 0.0% |
| 2017 Q2 | -832.28 Thousand AUD | 0.0% |
| 2017 Q4 | -958.02 Thousand AUD | 0.0% |
| 2017 FY | -1.79 Million AUD | 5.94% |
| 2016 FY | -1.9 Million AUD | -64.67% |
| 2016 Q4 | -1.08 Million AUD | 0.0% |
| 2016 Q2 | -821.32 Thousand AUD | 0.0% |
| 2015 FY | -1.15 Million AUD | 29.46% |
| 2015 Q2 | -391.3 Thousand AUD | 0.0% |
| 2015 Q4 | -764.57 Thousand AUD | 0.0% |
| 2014 Q1 | -447.17 Thousand AUD | 47.85% |
| 2014 FY | -1.63 Million AUD | 8.39% |
| 2014 Q4 | -543.15 Thousand AUD | -32.59% |
| 2014 Q3 | -409.64 Thousand AUD | 48.74% |
| 2014 Q2 | -799.07 Thousand AUD | -78.69% |
| 2013 FY | -1.78 Million AUD | 19.21% |
| 2013 Q4 | -857.51 Thousand AUD | -91.76% |
| 2013 Q3 | -447.17 Thousand AUD | 0.0% |
| 2013 Q2 | -447.17 Thousand AUD | 19.21% |
| 2013 Q1 | -553.49 Thousand AUD | 0.0% |
| 2012 Q3 | -553.49 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 FY | -2.21 Million AUD | 23.96% |
| 2012 Q1 | -727.86 Thousand AUD | 0.0% |
| 2012 Q2 | -553.49 Thousand AUD | 23.96% |
| 2011 Q2 | -727.86 Thousand AUD | -34.38% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | -2.91 Million AUD | -34.38% |
| 2011 Q1 | -541.66 Thousand AUD | 0.0% |
| 2011 Q3 | -727.86 Thousand AUD | 0.0% |
| 2010 FY | -2.16 Million AUD | -12.35% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -541.66 Thousand AUD | 0.0% |
| 2010 Q1 | -482.1 Thousand AUD | 0.0% |
| 2010 Q2 | -541.66 Thousand AUD | -12.35% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | -1.92 Million AUD | 24.61% |
| 2009 Q2 | -482.1 Thousand AUD | 24.61% |
| 2009 Q3 | -482.1 Thousand AUD | 0.0% |
| 2009 Q1 | -639.47 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -639.47 Thousand AUD | 0.0% |
| 2008 FY | -2.55 Million AUD | 41.41% |
| 2008 Q1 | -1.09 Million AUD | 0.0% |
| 2008 Q2 | -639.47 Thousand AUD | 41.41% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 FY | -4.36 Million AUD | -2.96% |
| 2007 Q3 | -1.09 Million AUD | 0.0% |
| 2007 Q2 | -1.09 Million AUD | -2.96% |
| 2007 Q1 | -1.06 Million AUD | 0.0% |
| 2006 FY | -4.24 Million AUD | -17.78% |
| 2006 Q2 | -1.06 Million AUD | -17.78% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q3 | -1.06 Million AUD | 0.0% |
| 2006 Q1 | -900.11 Thousand AUD | 0.0% |
| 2005 FY | -3.6 Million AUD | 0.0% |
| 2005 Q2 | -900.11 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -900.11 Thousand AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q2 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 91.403% |
| Adherium Limited | -11.98 Million AUD | 79.939% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 75.435% |
| Atomo Diagnostics Limited | -4.36 Million AUD | 44.873% |
| Anteris Technologies Ltd | -66.63 Million AUD | 96.392% |
| Control Bionics Limited | -5.92 Million AUD | 59.449% |
| CardieX Limited | -4.63 Million AUD | 48.112% |
| Compumedics Limited | -269 Thousand AUD | -793.81% |
| Cochlear Limited | 521.5 Million AUD | 100.461% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 50.055% |
| Cyclopharm Limited | -9.22 Million AUD | 73.936% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -48.931% |
| Nova Eye Medical Limited | -3.79 Million AUD | 36.678% |
| HeraMED Limited | -6.42 Million AUD | 62.596% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 86.32% |
| ImpediMed Limited | -19.03 Million AUD | 87.369% |
| InhaleRx Limited | -1.38 Million AUD | -73.413% |
| LBT Innovations Limited | -4.74 Million AUD | 49.275% |
| Micro-X Limited | -13.02 Million AUD | 81.543% |
| Neurotech International Limited | -5.58 Million AUD | 56.948% |
| OncoSil Medical Limited | -11.98 Million AUD | 79.937% |
| PolyNovo Limited | 1.16 Million AUD | 306.737% |
| Respiri Limited | -7 Million AUD | 65.653% |
| SomnoMed Limited | -3.84 Million AUD | 37.408% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 85.586% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 58.929% |